Addvise logo
sv_SE
sv_SE
search

ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex

By

ADDvise Group AB (publ) (the “Company” or “ADDvise”) has instructed the agent under the Company’s outstanding bonds 2025/2028 with ISIN SE0025011885 (the “Bonds”) to initiate a written procedure in which the Company requests that the bondholders approve certain amendments to the terms and conditions of the Bonds (the “Written Procedure”). The proposed amendments in the … Read more

ADDvise’s board of directors evaluates the public offer from Amplex

By

Amplex AB (“Amplex”) has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) (“ADDvise”) to transfer all shares and warrants in ADDvise to Amplex at a price of SEK 1.65 in cash for each class A and class B share and SEK 0.49 in cash for each warrant … Read more

ADDvise receives order worth USD 2.3 million

By

ADDvise Group’s subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3 million. The order involves design, paneling, and installation of a cleanroom and associated accessories for a new pharmaceutical manufacturing facility located in the United … Read more

ADDvise Group’s nomination committee for the Annual General Meeting 2026

By

In accordance with the resolution at the Annual General Meeting 2022 of ADDvise Group, the nomination committee for the Annual General Meeting 2026 shall comprise of representatives of the three largest shareholders by votes, according to the shareholders’ register as of 30 June 2025 maintained by Euroclear Sweden, and of the chairman of the board … Read more

Interim report 2025, January 1–September 30

By

Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive. The work on operational efficiency is having an effect and EBITA increased by SEK 1.0 million while the EBITA margin amounted to 15.5% (13.7%). Cash flow … Read more

Invitation to presentation of interim report January 1 – September 30, 2025

By

ADDvise Group publishes its interim report January 1 – September 30, 2025 on Thursday, October 23, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and CFO, Johan Irwe, will present the report. WebcastIf you wish to … Read more

Interim report 2025, January 1–June 30

By

In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow improved in the quarter, and EBITA was in line with last year with a stronger margin. Through the new capital structure, ADDvise’s annual interest expenses … Read more